首页 / 院系成果 / 成果详情页

Levetiracetam but not valproate inhibits function of CD8(+) T lymphocytes 期刊论文

编号：

ac223481-898c-4682-a216-345c3fd8c8da
作者：

Li, Gang^[1,3,4];Nowak, Mareike^[1,5];Bauer, Sebastian^[1];Schlegel, Kerstin^[2];Stei, Susanne^[2];Allenhoefer, Lena^[5];Waschbisch, Anne^[6];Tackenberg, Bjoern^[2];Hoellerhage, Matthias^[2];Hoeglinger, Guenter U.^[2];Wegner, Sven^[1];Wang, Xin(汪昕)^[4]Oertel, Wolfgang H.^[1];Rosenow, Felix^[1];Hamer, Hajo M.^[1,5];
语种：

English
期刊：

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY ISSN：1059-1311 2013 年 22 卷 6 期 (462 - 466) ; JUL
收录：
关键词：

Levetiracetam Valproate CD8(+) T lymphocytes Apoptosis SV2A Perforin
摘要：

Purpose: To further elucidate possible immune-modulatory effects of valproate (VPA) or levetiracetam (LEV), we investigated their influence on apoptosis and cytotoxic function of CD8(+) T lymphocytes in humans. Methods: In 15 healthy subjects (9 female (60%), 35.7 +/- 12.1 years), apoptosis and cytotoxic function of CD8(+) T lymphocytes were measured using flow cytometry following in vitro exposure to LEV (5 mg/L and 50 mg/L) and VPA (10 mg/L and 100 mg/L). Apoptosis rates were determined after incubation with LEV or VPA for 1 h or 24 h. Cytotoxic function was assessed following 2 h stimulation with mixed virus peptides, using perforin release, CD107a/b expression and proliferation. The presence of synaptic vesicle protein 2A (SV2A) was investigated in human CD8(+) T lymphocytes by flow cytometry analysis, Western blot and real time polymerase chain reaction (rtPCR). Results: High concentration of LEV decreased perforin release of CD8(+) T lymphocytes (LEV 50 mg/L vs. CEF only: 21.4% (interquartile range (IQR) 16.5-35.9%) vs. 16.6% (IQR 12-24.9%), p = 0.002). LEV had no influence on apoptosis and proliferation (p > 0.05). VPA (100 mg/L) slowed apoptosis of CD8(+) T lymphocytes after 24 h (VPA 100 mg/L vs. control: 7.3% (IQR 5.4-9.5%) vs. 11.3% (IQR 8.2-15.1%), p < 0.001), but had no effects on perforin release (p > 0.05). SV2A protein was detected in CD8(+) T lymphocytes. Conclusion: LEV decreased degranulation of CD8(+) T lymphocytes which may contribute to the increased incidence of upper respiratory tract infections in LEV treated patients. Inhibition of SV2A may be responsible for this effect. (C) 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
推荐引用方式
GB/T 7714：

Li Gang,Nowak Mareike,Bauer Sebastian, et al. Levetiracetam but not valproate inhibits function of CD8(+) T lymphocytes [J].SEIZURE-EUROPEAN JOURNAL OF EPILEPSY,2013,22(6):462-466.
APA：

Li Gang,Nowak Mareike,Bauer Sebastian,Schlegel Kerstin,&Hamer Hajo M..(2013).Levetiracetam but not valproate inhibits function of CD8(+) T lymphocytes .SEIZURE-EUROPEAN JOURNAL OF EPILEPSY,22(6):462-466.
MLA：

Li Gang, et al. "Levetiracetam but not valproate inhibits function of CD8(+) T lymphocytes" .SEIZURE-EUROPEAN JOURNAL OF EPILEPSY 22,6(2013):462-466.

浏览次数：3  下载次数：0

分享到：

浏览次数：3

下载次数：0

打印次数：0